The Blood-Retina Barrier

Tight Junctions and Barrier Modulation
  • Matthew Campbell
  • Peter Humphries
Part of the Advances in Experimental Medicine and Biology book series (AEMB)


The blood-retina barrier (BRB) is composed of both an inner and an outer barrier. The outer BRB refers to the barrier formed at the retinal pigment epithelial (RPE) cell layer and functions, in part, to regulate the movement of solutes and nutrients from the choroid to the sub-retinal space. In contrast, the inner BRB, similar to the blood brain barrier (BBB) is located in the inner retinal microvasculature and comprises the microvascular endothelium which line these vessels. The tight junctions located between these cells mediate highly selective diffusion of molecules from the blood to the retina and the barrier is essential in maintaining retinal homeostasis. In this chapter, we summarize the key differences between the iBRB and oBRB and outline the molecular constituents of the tight junctions associated with the iBRB. We also describe a process for modulation of the iBRB to enhance systemic delivery of therapeutics to the retina, a technology which may pave the way for safer and more effective therapies for retinal diseases.


Tight Junction Diabetic Retinopathy Tight Junction Protein Paracellular Permeability Blood Retina Barrier 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Forrester JV, Dick AD, McMenamin PG, eds. The Eye. Philadelphia: Elsevier Health Sciences, 2001.Google Scholar
  2. 2.
    Antonetti DA, Lieth E, Barber AJ, Gardner TW. Molecular mechanisms of vascular permeability in diabetic retinopathy. Semin Ophthalmol 1999; 14:240–8.PubMedCrossRefGoogle Scholar
  3. 3.
    Marmorstein AD, Finnemann SC, Bonilha VL, Rodriguez-Boulan E. Morphogenesis of the retinal pigment epithelium: toward understanding retinal degenerative diseases. Ann N Y Acad Sci 1998; 857:1–12.PubMedCrossRefGoogle Scholar
  4. 4.
    Marneros AG, Fan J, Yokoyama Y et al. Vascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual function. Am J Pathol 2005; 167:1451–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Bazzoni G, Martinez-Estrada OM, Orsenigo F et al. Interaction of junctional adhesion molecule with the tight junction components ZO-1, cingulin, and occludin. J Biol Chem 2000; 275:20520–6.PubMedCrossRefGoogle Scholar
  6. 6.
    Bazzoni G, Martinez-Estrada OM, Mueller F et al. Homophilic interaction of junctional adhesion molecule. J Biol Chem 2000; 275:30970–6.PubMedCrossRefGoogle Scholar
  7. 7.
    Bazzoni G. The JAM family of junctional adhesion molecules. Curr Opin Cell Biol 2003; 15:525–30.PubMedCrossRefGoogle Scholar
  8. 8.
    Bazzoni G, Dejana E. Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev 2004; 84:869–901.PubMedCrossRefGoogle Scholar
  9. 9.
    Farquhar MG, Palade GE. Junctional complexes in various epithelia. J Cell Biol 1963; 17:375–412.PubMedCrossRefGoogle Scholar
  10. 10.
    Sakakibara A, Furuse M, Saitou M et al. Possible involvement of phosphorylation of occludin in tight junction formation. J Cell Biol 1997; 137:1393–401.PubMedCrossRefGoogle Scholar
  11. 11.
    Fanning AS, Anderson JM. PDZ domains and the formation of protein networks at the plasma membrane. Curr Top Microbiol Immunol 1998; 228:209–33.PubMedGoogle Scholar
  12. 12.
    Riesen FK, Rothen-Rutishauser B, Wunderli-A llenspach H. A ZO1-GFP fusion protein to study the dynamics of tight junctions in living cells. Histochem Cell Biol 2002; 117:307–15.PubMedCrossRefGoogle Scholar
  13. 13.
    Zahraoui A, Louvard D, Galli T. Tight junction, a platform for trafficking and signaling protein complexes. J Cell Biol 2000; 151:F31–6.PubMedCrossRefGoogle Scholar
  14. 14.
    Zahraoui A. [Tight junctions, a platform regulating cell proliferation and polarity]. Med Sci (Paris) 2004; 20:580–5.CrossRefGoogle Scholar
  15. 15.
    Balda MS, Matter K. The tight junction protein ZO-1 and an interacting transcription factor regulate ErbB-2 expression. EMBO J 2000; 19:2024–33.PubMedCrossRefGoogle Scholar
  16. 16.
    Balda MS, Garrett MD, Matter K. The ZO-1-associated Y-box factor ZONAB regulates epithelial cell proliferation and cell density. J Cell Biol 2003; 160:423–32.PubMedCrossRefGoogle Scholar
  17. 17.
    Vinores SA, Campochiaro PA, Lee A et al. Localization of blood-retinal barrier breakdown in human pathologic specimens by immunohistochemical staining for albumin. Lab Invest 1990; 62:742–50.PubMedGoogle Scholar
  18. 18.
    Vinores SA, Kuchle M, Derevjanik NL et al. Blood-retinal barrier breakdown in retinitis pigmentosa: light and electron microscopic immunolocalization. Histol Histopathol 1995; 10:913–23.PubMedGoogle Scholar
  19. 19.
    Dorchy H. Characterization of early stages of diabetic retinopathy. Importance of the breakdown of the blood-retinal barrier. Diabetes Care 1993; 16:1212–4.PubMedGoogle Scholar
  20. 20.
    Dorchy H, Toussaint D. Fluorescein leakage: First sign of juvenile diabetic retinopathy. Lancet 1978; 1:1200.PubMedCrossRefGoogle Scholar
  21. 21.
    Carney MD, Paylor RR, Cunha-Vaz JG et al. Iatrogenic choroidal neovascularization in sickle cell retinopathy. Ophthalmology 1986; 93:1163–8.PubMedCrossRefGoogle Scholar
  22. 22.
    Mitic LL, Schneeberger EE, Fanning AS, Anderson JM. Connexin-occludin chimeras containing the ZO-binding domain of occludin localize at MDCK tight junctions and NRK cell contacts. J Cell Biol 1999; 146:683–93.PubMedCrossRefGoogle Scholar
  23. 23.
    Furuse M, Hirase T, Itoh M et al. Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol 1993; 123:1777–88.PubMedCrossRefGoogle Scholar
  24. 24.
    Furuse M, Itoh M, Hirase T et al. Direct association of occludin with ZO-1 and its possible involvement in the localization of occludin at tight junctions. J Cell Biol 1994; 127:1617–26.PubMedCrossRefGoogle Scholar
  25. 25.
    González-Mariscal L, Betanzos A, Avila-Flores A. MAGUK proteins: structure and role in the tight junction. Semin Cell Dev Biol 2000; 11:315–24.PubMedCrossRefGoogle Scholar
  26. 26.
    Gonzalez-Mariscal L, Namorado MC, Martin D et al. Tight junction proteins ZO-1, ZO-2, and occludin along isolated renal tubules. Kidney Int 2000; 57:2386–402.PubMedCrossRefGoogle Scholar
  27. 27.
    Gonzalez-Mariscal L, Betanzos A, Nava P, Jaramillo BE. Tight junction proteins. Prog Biophys Mol Biol 2003; 81:1–44.PubMedCrossRefGoogle Scholar
  28. 28.
    Feldman GJ, Mullin JM, Ryan MP. Occludin: structure, function and regulation. Adv Drug Deliv Rev 2005; 57:883.PubMedCrossRefGoogle Scholar
  29. 29.
    McCarthy KM, Skare IB, Stankewich MC et al. Occludin is a functional component of the tight junction. J Cell Sci 1996; 109:2287–98.PubMedGoogle Scholar
  30. 30.
    Brankin B, Campbell M, Canning P et al. Endostatin modulates VEGF-mediated barrier dysfunction in the retinal microvascular endothelium. Exp Eye Res 2005; 81:22–31.PubMedCrossRefGoogle Scholar
  31. 31.
    Campbell M, Collery R, McEvoy A et al. Involvement of MAPKs in endostatin-mediated regulation of blood-retinal barrier function. Curr Eye Res 2006; 31:1033–45.PubMedCrossRefGoogle Scholar
  32. 32.
    Antonetti DA, Barber AJ, Hollinger LA et al. Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors. J Biol Chem 1999; 274:23463–7.PubMedCrossRefGoogle Scholar
  33. 33.
    Wong V. Phosphorylation of occludin correlates with occludin localization and function at the tight junction. Am J Physiol 1997; 273:C1859–67.PubMedGoogle Scholar
  34. 34.
    Staddon JM, Smales C, Schulze C et al. p120, a p120-related protein (p100), and the cadherin/catenin complex. J Cell Biol 1995; 130:369–81.PubMedCrossRefGoogle Scholar
  35. 35.
    Kale G, Naren AP, Sheth P, Rao RK. Tyrosine phosphorylation of occludin attenuates its interactions with ZO-1, ZO-2, and ZO-3. Biochem Biophys Res Commun 2003; 302:324–9.PubMedCrossRefGoogle Scholar
  36. 36.
    Rao RK, Baker RD, Baker SS et al. Oxidant-induced disruption of intestinal epithelial barrier function: role of protein tyrosine phosphorylation. Am J Physiol 1997; 273:G812–23.PubMedGoogle Scholar
  37. 37.
    Saitou M, Fujimoto K, Doi Y et al. Occludin-deficient embryonic stem cells can differentiate into polarized epithelial cells bearing tight junctions. J Cell Biol 1998; 141:397–408.PubMedCrossRefGoogle Scholar
  38. 38.
    Stevenson BR, Siliciano JD, Mooseker MS, Goodenough DA. Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia. J Cell Biol 1986; 103:755–66.PubMedCrossRefGoogle Scholar
  39. 39.
    Woods DF, Bryant PJ. ZO-1, DlgA and PSD-95/SAP90: homologous proteins in tight, septate and synaptic cell junctions. Mech Dev 1993; 44:85–9.PubMedCrossRefGoogle Scholar
  40. 40.
    Weng Z, Rickles RJ, Feng S et al. Structure-function analysis of SH3 domains: SH3 binding specificity altered by single amino acid substitutions. Mol Cell Biol 1995; 15:5627–34.PubMedCentralPubMedGoogle Scholar
  41. 41.
    Balda MS, Anderson JM. Two classes of tight junctions are revealed by ZO-1 isoforms. Am J Physiol 1993; 264:C918–24.PubMedGoogle Scholar
  42. 42.
    Gottardi CJ, Arpin M, Fanning AS, Louvard D. The junction-associated protein, zonula occludens-1, localizes to the nucleus before the maturation and during the remodeling of cell-cell contacts. Proc Natl Acad Sci USA 1996; 93:10779–84.PubMedCrossRefGoogle Scholar
  43. 43.
    Itoh M, Nagafuchi A, Moroi S, Tsukita S. Involvement of ZO-1 in cadherin-based cell adhesion through its direct binding to alpha catenin and actin filaments. J Cell Biol 1997; 138:181–92.PubMedCrossRefGoogle Scholar
  44. 44.
    Itoh M, Nagafuchi A, Yonemura S et al. The 220-kD protein colocalizing with cadherins in non-epithelial cells is identical to ZO-1, a tight junction-associated protein in epithelial cells: cDNA cloning and immunoelectron microscopy. J Cell Biol 1993; 121:491–502.PubMedCrossRefGoogle Scholar
  45. 45.
    Itoh M, Morita K, Tsukita S. Characterization of ZO-2 as a MAGUK family member associated with tight as well as adherens junctions with a binding affinity to occludin and alpha catenin. J Biol Chem 1999; 274:5981–6.PubMedCrossRefGoogle Scholar
  46. 46.
    Giepmans BN, Moolenaar WH. The gap junction protein connexin43 interacts with the second PDZ domain of the zona occludens-1 protein. Curr Biol 1998; 8:931–4.PubMedCrossRefGoogle Scholar
  47. 47.
    Balda MS, Garrett MD, Matter K. The ZO-1-associated Y-box factor ZONAB regulates epithelial cell proliferation and cell density. J Cell Biol 2003; 160:423–32.PubMedCrossRefGoogle Scholar
  48. 48.
    Kausalya PJ, Reichert M, Hunziker W. Connexin45 directly binds to ZO-1 and localizes to the tight junction region in epithelial MDCK cells. FEBS Lett 2001; 505:92–6.PubMedCrossRefGoogle Scholar
  49. 49.
    Hoover KB, Liao SY, Bryant PJ. Loss of the tight junction MAGUK ZO-1 in breast cancer: relationship to glandular differentiation and loss of heterozygosity. Am J Pathol 1998; 153:1767–73.PubMedCrossRefGoogle Scholar
  50. 50.
    Tserentsoodol N, Shin BC, Suzuki T, Takata K. Colocalization of tight junction proteins, occludin and ZO-1, and glucose transporter GLUT1 in cells of the blood-ocular barrier in the mouse eye. Histochem Cell Biol 1998; 110:543–51.PubMedCrossRefGoogle Scholar
  51. 51.
    Campbell M, Humphries M, Kennan A et al. Aberrant retinal tight junction and adherens junction protein expression in an animal model of autosomal recessive Retinitis pigmentosa: the Rho(-/-) mouse. Exp Eye Res 2006; 83:484–92.PubMedCrossRefGoogle Scholar
  52. 52.
    Campbell M, Humphries M, Kenna P et al. Altered expression and interaction of adherens junction proteins in the developing OLM of the Rho(-/-) mouse. Exp Eye Res 2007; 85:714–20.PubMedCrossRefGoogle Scholar
  53. 53.
    Freddo TF. Intercellular junctions of the iris epithelia in Macaca mulatta. Invest Ophthalmol Vis Sci 1984; 25:1094–104.PubMedGoogle Scholar
  54. 54.
    Wittchen ES, Haskins J, Stevenson BR. Protein interactions at the tight junction. Actin has multiple binding partners, and ZO-1 forms independent complexes with ZO-2 and ZO-3. J Biol Chem 1999; 274:35179–85.PubMedCrossRefGoogle Scholar
  55. 55.
    D’Atri F, Nadalutti F, Citi S. Evidence for a functional interaction between cingulin and ZO-1 in cultured cells. J Biol Chem 2002; 277:27757–64.CrossRefGoogle Scholar
  56. 56.
    Betanzos A, Huerta M, Lopez-Bayghen E et al. The tight junction protein ZO-2 associates with Jun, Fos and C/EBP transcription factors in epithelial cells. Exp Cell Res 2004; 292:51–66.PubMedCrossRefGoogle Scholar
  57. 57.
    Jaramillo BE, Ponce A, Moreno J et al. Characterization of the tight junction protein ZO-2 localized at the nucleus of epithelial cells. Exp Cell Res 2004; 297:247–58.PubMedCrossRefGoogle Scholar
  58. 58.
    Haskins J, Gu L, Wittchen ES et al. ZO-3, a novel member of the MAGUK protein family found at the tight junction, interacts with ZO-1 and occludin. J Cell Biol 1998; 141:199–208.PubMedCrossRefGoogle Scholar
  59. 59.
    Inoko A, Itoh M, Tamura A et al. Expression and distribution of ZO-3, a tight junction MAGUK protein, in mouse tissues. Genes Cells 2003; 8:837–45.PubMedCrossRefGoogle Scholar
  60. 60.
    Islas S, Vega J, Ponce L, Gonzalez-Mariscal L. Nuclear localization of the tight junction protein ZO-2 in epithelial cells. Exp Cell Res 2002; 274:138–48.PubMedCrossRefGoogle Scholar
  61. 61.
    Furuse M, Fujita K, Hiiragi T et al. Claudin-1 and-2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 1998; 141:1539–50.PubMedCrossRefGoogle Scholar
  62. 62.
    Furuse M, Sasaki H, Fujimoto K, Tsukita S. A single gene product, claudin-1 or-2, reconstitutes tight junction strands and recruits occludin in fibroblasts. J Cell Biol 1998; 143:391–401.PubMedCrossRefGoogle Scholar
  63. 63.
    Inai T, Kobayashi J, Shibata Y. Claudin-1 contributes to the epithelial barrier function in MDCK cells. Eur J Cell Biol 1999; 78:849–55.PubMedCrossRefGoogle Scholar
  64. 64.
    Nitta T, Hata M, Gotoh S et al. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 2003; 161:653–60.PubMedCrossRefGoogle Scholar
  65. 65.
    Masland RH. The fundamental plan of the retina. Nat Neurosci 2001; 4:877–86.PubMedCrossRefGoogle Scholar
  66. 66.
    Swaroop A, Chew EY, Rickman CB et al. Unraveling a multifactorial late-onset disease: from genetic susceptibility to diseasemechanisms for age-related macular degeneration. Annu Rev Genomics Hum Genet 2009, 10:19.43.PubMedCentralPubMedCrossRefGoogle Scholar
  67. 67.
    Resnikoff S, Pascolini D, Etya’ale D et al. Global data on visual impairment in the year 2002. Bull World Health Organ 2004; 82:844–51.PubMedCentralPubMedGoogle Scholar
  68. 68.
    CATT Research Group. Martin DF, Maguire MG, Ying GS et al. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 2011; 364:1897–908.PubMedCrossRefGoogle Scholar
  69. 69.
    Fong DS, Girach A, Boney A. Visual side effects of successful scatter laser photocoagulation surgery for proliferative diabetic retinopathy: a literature review (2007) Retina. Sep; 27(7):816–24.CrossRefGoogle Scholar
  70. 70.
    Pardridge WM. Molecular Trojan horses for blood-brain barrier drug delivery. Curr Opin Pharmacol 2006; 6:494–500.PubMedCrossRefGoogle Scholar
  71. 71.
    Piontek J, Winkler L, Wolburg H et al. Formation of tight junction: determinants of homophilic interaction between classic claudins. FASEB J 2008; 22:146–58.PubMedCrossRefGoogle Scholar
  72. 72.
    Campbell M, Kiang AS, Kenna PF et al. RNAi-mediated reversible opening of the blood-brain barrier. 2008. J Gene Med. Aug;10(8):930–47.CrossRefGoogle Scholar
  73. 73.
    Campbell M, Nguyen ATH, Kiang AS et al. An experimental platform for systemic drug delivery to the retina. Proc Natl Acad Sci USA 2009; 106:17817–22.PubMedCrossRefGoogle Scholar
  74. 74.
    Maguire AM, Simonelli F, Pierce EA et al. Safety and efficacy of gene transfer for Leber’s congenital amaurosis. N Engl J Med 2008; 358:2240–8.PubMedCentralPubMedCrossRefGoogle Scholar
  75. 75.
    Bainbridge JW, Smith AJ, Barker SS et al. Effect of gene therapy on visual function in Leber’s congenital amaurosis. N Engl J Med 2008; 358:2231–9.PubMedCrossRefGoogle Scholar
  76. 76.
    Hauswirth WW, Aleman TS, Kaushal S et al. Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial. Hum Gene Ther 2008; 19:979–90.PubMedCrossRefGoogle Scholar
  77. 77.
    Foust KD, Nurre E, Montgomery CL et al. Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat Biotechnol 2009; 27:59–65.PubMedCentralPubMedCrossRefGoogle Scholar
  78. 78.
    Campbell M, Humphries MM, Nguyen ATH et al. Systemic low molecular weight drug delivery to pre-selected neuronal regions. EMBO Mol Med 2011; 3:235–45.PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Landes Bioscience and Springer Science+Business Media 2013

Authors and Affiliations

  1. 1.Ocular Genetics Unit, Department of GeneticsTrinity College DublinDublinIreland

Personalised recommendations